Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Estetrol-drospirenone Combined Oral Contraceptive Pill on Arterial Vascular Risks

NCT07536763 is registered in ClinicalTrials.gov with Dr. Hang Wun Raymond Li as lead sponsor.

NCT NCT07536763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07536763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Estetrol-drospirenone Combined Oral Contraceptive Pill on Arterial Vascular Risks
Lead sponsor
Dr. Hang Wun Raymond Li
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
June 30, 2029
Enrollment
98 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception